Does ROSUVASTATIN\ROSUVASTATIN Cause Hyperlipidaemia? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperlipidaemia have been filed in association with ROSUVASTATIN\ROSUVASTATIN. This represents 1.1% of all adverse event reports for ROSUVASTATIN\ROSUVASTATIN.
6
Reports of Hyperlipidaemia with ROSUVASTATIN\ROSUVASTATIN
1.1%
of all ROSUVASTATIN\ROSUVASTATIN reports
1
Deaths
4
Hospitalizations
How Dangerous Is Hyperlipidaemia From ROSUVASTATIN\ROSUVASTATIN?
Of the 6 reports, 1 (16.7%) resulted in death, 4 (66.7%) required hospitalization.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN\ROSUVASTATIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN\ROSUVASTATIN Cause?
Dyspnoea (79)
Asthma (77)
Pneumonia (52)
Acute kidney injury (50)
Wheezing (50)
Myalgia (48)
Drug hypersensitivity (46)
Fatigue (44)
Pain (44)
Rhabdomyolysis (43)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which ROSUVASTATIN\ROSUVASTATIN Alternatives Have Lower Hyperlipidaemia Risk?
ROSUVASTATIN\ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN\ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN\ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN\ROSUVASTATIN vs ROXITHROMYCIN
ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB